IP Library Granted Patent US 12,123,048
Granted Patent B2
US 12,123,048 · App. 17/298,872 · Granted Oct 22, 2024

Fluorinated 4′-alkylumbelliferyl a-D-glucopyranosides, biological sterilization indicators including the same and methods of using the same

Inventors: Tonya D. Bonilla (Woodbury, MN); Stephen B. Roscoe (Woodbury, MN); George W. Griesgraber (Eagan, MN)
Assignee: Solventum Intellectual Property Company
C12Q1/22A61L2/28C07H17/075G01N21/6428G01N2021/6439
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,123,048
App. No.
17/298,872
Granted
Oct 22, 2024
Kind
B2
Abstract

A self-contained biological sterilization indicator comprises: a housing; bacterial spores comprising, and/or capable of producing, an enzyme capable of catalyzing cleavage of an enzyme substrate; and a frangible container containing a composition, wherein the composition comprises the enzyme substrate, wherein if the frangible container is broken the composition will contact the bacterial spores to form a mixture having an initial pH in the range from 6.0 to 9.0. The enzyme substrate comprises a fluorinated 4′-alkylumbelliferyl α-D-glucopyranoside represented by the structural formula (I) wherein one of R 1 and R 2 is F and the other is H, and R 3 is an alkyl group having from 1 to 12 carbon atoms. A biological sterilization indicator comprising a kit containing isolated components comprising (i) bacterial spores comprising, and/or capable of producing, an enzyme capable of catalyzing cleavage of the enzyme substrate and a method of assessing efficacy of a sterilization process are also disclosed.

Claims (47)

1. A fluorinated 4′-alkylumbelliferyl α-D-glucopyranoside represented by the structural formula

wherein:

one of R 1 and R 2 is F and the other is H, and

R 3 is an alkyl group having from 1 to 12 carbon atoms.

2. The fluorinated 4′-alkylumbelliferyl α-D-glucopyranoside of claim 1 , wherein R 3 is an alkyl group having 1 to 4 carbon atoms.

3. The fluorinated 4′-alkylumbelliferyl α-D-glucopyranoside of claim 1 , wherein R 1 is F, R 2 is H, and R 3 is methyl.

4. The fluorinated 4′-alkylumbelliferyl α-D-glucopyranoside of claim 1 , wherein R 1 is H, R 2 is F, and R 3 is methyl.

5. A self-contained biological sterilization indicator comprising:

a housing,

bacterial spores comprising, and/or capable of producing, an enzyme capable of catalyzing cleavage of an enzyme substrate represented by the structural formula

wherein:

one of R 1 and R 2 is F and the other is H, and

R 3 is an alkyl group having from 1 to 12 carbon atoms; and

a frangible container containing a composition, wherein the composition comprises the enzyme substrate, wherein if the frangible container is broken the composition will contact the bacterial spores to form a mixture having an initial pH in the range from 6.0 to 9.0.

6. The self-contained biological sterilization indicator of claim 5 , wherein the self-contained biological sterilization indicator is disposed inside a process-challenge device.

7. The self-contained biological sterilization indicator of claim 5 , wherein R 3 is an alkyl group having 1 to 4 carbon atoms.

8. The self-contained biological sterilization indicator of claim 5 , wherein the self-contained biological sterilization indicator is capable of determining efficacy of two or more cycles chosen from the powerset of 121 gravity, 121 pre-vac, 121 SFPP, 132 gravity, 132 pre-vac, 132 SFPP, 134 pre-vac, 134 SFPP, 135 gravity, 135 pre-vac, and 135 SFPP.

9. The self-contained biological sterilization indicator of claim 5 , wherein the enzyme substrate is represented by the structural formula

10. The self-contained biological sterilization indicator of claim 5 , wherein the enzyme substrate is represented by the structural formula

11. The self-contained biological sterilization indicator of claim 5 , wherein the mixture has an initial pH in the range from 6.0 to 7.0.

12. A biological sterilization indicator comprising a kit containing isolated components comprising:

(i) bacterial spores comprising, and/or capable of producing, an enzyme capable of catalyzing cleavage of an enzyme substrate represented by the structural formula

wherein:

one of R 1 and R 2 is F and the other is H, and

R 3 is an alkyl group having from 1 to 12 carbon atoms; and

(ii) a composition, wherein the composition comprises the enzyme substrate, wherein if the composition is brought into contact with the bacterial spores to form a mixture, the mixture will have an initial pH in the range from 6.0 to 9.0.

13. The biological sterilization indicator of claim 12 , wherein at least one of components (i) or (ii) is disposed inside a process-challenge device.

14. The biological sterilization indicator of claim 12 , wherein R 3 is an alkyl group having 1 to 4 carbon atoms.

15. The biological sterilization indicator of claim 12 , wherein the composition is a liquid composition.

16. The biological sterilization indicator of claim 12 , wherein the enzyme substrate is represented by the structural formula

17. The biological sterilization indicator of claim 12 , wherein the enzyme substrate is represented by the structural formula

18. The biological sterilization indicator of claim 12 , wherein the mixture has an initial pH in the range from 6.0 to 7.0.

19. A method of assessing efficacy of a sterilization process, the method comprising sequentially:

a) providing a biological sterilization indicator comprising:

bacterial spores comprising, and/or capable of producing, an enzyme capable of catalyzing cleavage of an enzyme substrate represented by the structural formula

wherein:

one of R 1 and R 2 is F and the other is H, and

R 3 is an alkyl group having from 1 to 12 carbon atoms; and

a composition, wherein the composition comprises the enzyme substrate, wherein if the composition is brought into contact with the bacterial spores to form a mixture, the mixture will have an initial pH in the range from 6.0 to 9.0;

b) subjecting at least the bacterial spores to the sterilization process;

c) contacting the composition with the bacterial spores; and

d) evaluating efficacy of the sterilization process.

20. The method of claim 19 , wherein step d) comprises fluorescence spectroscopy.

21. The method of claim 19 , wherein R 3 is an alkyl group having 1 to 4 carbon atoms.

22. The method of claim 19 , wherein the enzyme substrate is represented by the structural formula

23. The method of claim 19 , wherein the enzyme substrate is represented by the structural formula

24. The method of claim 19 , wherein the composition and the bacterial spores are both contained within a housing.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066443/0600 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2021
From: BONILLA, TONYA D.; ROSCOE, STEPHEN B.; GRIESGRABER, GEORGE W.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 056405/0073 →
Continuity (2)
Provisional Application 62776308 · Dec 6, 2018
Related Publication 20220017939A1 · Jan 20, 2022